JDRF Blog

Latest in Research

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • Advancing the Cure with Type 1 Diabetes Clinical Trials

    May 20, 2019

     JDRF funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with this disease....

  • Closer to Cure: Renewed Funding for Type 1 Diabetes UK Immunotherapy Consortium (T1D UK)

    May 8, 2019

    More than 400,000 people in the United Kingdom and 1.25 million Americans have type 1 diabetes (T1D), a disease for which there...

  • Want to Stave Off Type 1 Diabetes? Beta Cell Proliferation May Be the Key

    May 6, 2019

    In Nature Metabolism, JDRF-funded researchers—including the lead author, Ercument Dirice, Ph.D., and senior author, Rohit Kulkarni, M.D., Ph.D.—found an unidentified piece of...

  • A DIY Approach to Artificial Pancreas Technology

    May 2, 2019

    What do Aaron Kowalski, Ph.D., president and CEO of JDRF, and Jeremy Pettus, M.D., an endocrinologist at the University of California San...

  • End-Stage Kidney Disease: A Possible Biomarker of 10-Year Risk—and Therapeutic Target—for People with T1D

    April 23, 2019

    In the United States, diabetic kidney disease, or DKD, is responsible for more than half of all new cases of end-stage renal...

  • What is nPOD?

    April 17, 2019

    The human pancreas is very difficult to study, as JDRF-funded scientists well know. It cannot be imaged or safely biopsied from a...

  • ATTD Conference Brings Together Top Minds in Diabetes Research

    February 19, 2019

    Each year diabetes researchers from all over the world gather for the annual meeting of the Advanced Technologies & Treatments for Diabetes...

  • JDRF Drives Next-Generation Type 1 Diabetes Research With New Partnerships & Breakthrough Science

    December 22, 2018

    JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today that it made progressive advances this year on its...